NasdaqCM:NUTXHealthcare
Nutex Health (NUTX): Reassessing Valuation After New Legal Investigation and Short-Seller Allegations
Legal probe reshapes the backdrop for Nutex Health stock
The Schall Law Firm’s new investigation into Nutex Health (NUTX), sparked by Blue Orca Capital’s critical report on its billing arbitration practices, adds fresh legal uncertainty at a time when the stock has been rebounding.
See our latest analysis for Nutex Health.
That backdrop makes Nutex’s sharp recovery even more striking, with a year to date share price return of 432.52% and a 1 year total shareholder return of 428.71%. However,...